Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
APOBEC3F is a member of the cytidine deaminase gene family. De plus, nous expédions APOBEC3F Protéines (4) et et beaucoup plus de produits pour cette protéine.
Showing 10 out of 42 products:
Human Polyclonal APOBEC3F Primary Antibody pour ELISA, WB - ABIN566935
Han, Wang, Dang, Zheng: APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication. dans PLoS pathogens 2008
Show all 2 Pubmed References
APOBEC3DE (Montrer APOBEC3D Anticorps) binds to itself, APOBEC3F, and APOBEC3G (Montrer APOBEC3G Anticorps) and antagonizes APOBEC3F and, to a lesser extent, APOBEC3G (Montrer APOBEC3G Anticorps) restriction of hepatitis B virus replication.
These results indicate that APOBEC3 proteins can be copackaged and can comutate the same genomes, and can cooperate to inhibit HIV replication.
an APOBEC3F/APOBEC3G (Montrer APOBEC3G Anticorps) hetero-oligomer can form that has unique properties compared to each APOBEC3 alone. This hetero-oligomer has increased efficiency of virus hypermutation, raising the idea that we still may not fully realize the antiviral mechanisms of endogenous APOBEC3 enzymes. Hetero-oligomerization may be a mechanism to increase their antiviral activity in the presence of Vif (Montrer BTG1 Anticorps).
virus adaptation and computational studies to interrogate the APOBEC3F-Vif (Montrer BTG1 Anticorps) interface and build a robust structural model; taken together with mutagenesis results, propose a wobble model to explain how HIV-1 Vif (Montrer BTG1 Anticorps) has evolved to bind different APOBEC3 enzymes
Findings support a role for APOBEC3G (Montrer APOBEC3G Anticorps)/F proteins in the generation of plasma drug-resistant minority human immunodeficiency virus type 1 variants (DRMVs). However, this role seems to be limited to a small subset of mutations and does not explain most of the DRMVs evaluated.
Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from hepatitis b virus-hepatocellular carcinoma patients.
Our results provide genetic epidemiological evidence that A3F(APOBEC3F ) modulates HIV-1/AIDS disease progression
Six residues located within the conserved HIV-1 Vif (Montrer BTG1 Anticorps) F1-, F2-, and F3-box motifs are essential for both APOBEC3C (Montrer APOBEC3C Anticorps) and APOBEC3F degradation, and an additional four residues are uniquely required for APOBEC3F degradation.
This study showed for the first time a high level of APOBEC3F/3G editing in HIV-2 sequences from antiretroviral-naive patients.
APOBEC3D (Montrer APOBEC3D Anticorps)/F and APOBEC3G (Montrer APOBEC3G Anticorps) fundamentally work as restriction factors against HIV-1 in vivo
APOBEC3F/G-specific responses in HIV-1-infected rhesus macaques are CD8 (Montrer CD8A Anticorps)+ T cell mediated.
Increased APOBEC3G (Montrer APOBEC3G Anticorps) and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.
APOBEC3 proteins restrict xenotropic murine leukemia virus-related virus infections in a Macaca mulatta model.
These results strongly imply that human and porcine APOBEC3 could inhibit porcine endogenous retroviruses replication in vivo, thereby reducing the risk of infection of human cells in the context of pig-to-human xenotransplantation.
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been identified.
DNA dC->dU-editing enzyme APOBEC-3F
, apolipoprotein B mRNA editing enzyme cytidine deaminase
, apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F
, induced upon T-cell activation
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
, apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3F